Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 325140

Sort by

Sort Order Select

Journal Articles

Remestemcel-L-rknd (Ryoncil): the first approved cellular therapy for steroid-refractory acute GVHD

Aaron M. Etra, James L.M. Ferrara, John E Levine

Blood blood.2025028553.

https://doi.org/10.1182/blood.2025028553

Published: 2025

Journal Articles

Mitochondrial DNA via recipient TLR9 acts as a potent first-hit in murine transfusion-related acute lung injury (TRALI)

Johan Rebetz, Hilma Cederholm, David McGauran, Ellen Moore, Catherine Chi, Karlijn Tabak, Maria Allhorn, Martin L Olsson, Arne Egesten, John W. Semple, Genevieve Marcoux

Blood blood.2025028794.

https://doi.org/10.1182/blood.2025028794

Published: 2025

Includes: Supplemental data

Journal Articles

F8 gene variants influence the response to desmopressin in hemophilia A carriers

Benoît Guillet, Roseline D'Oiron, Marc Trossaert, Bénédicte Wibaut, Brigitte Pan-Petesch, Birgit Frotscher, Fabienne Genre-Volot, Laurent Ardillon, Stéphanie Desage, Céline Falaise, Christine Biron-Andreani, Vincent Cussac, Brigitte Tardy, Yoann Huguenin, Herve Chambost, Sophie Bayart, Sabine-Marie Castet, Xavier Delavenne

Blood blood.2025029829.

https://doi.org/10.1182/blood.2025029829

Published: 2025

Includes: Supplemental data

Journal Articles

Artificial Intelligence in Hematology

Aziz Nazha, Olivier Elemento, Sanjay Ahuja, Barbara D Lam, Moses Miles, Roni Shouval, Shannon K. McWeeney, Shireen Sirhan, Andrew Srisuwananukorn, Torsten Haferlach

Blood blood.2025029876.

https://doi.org/10.1182/blood.2025029876

Published: 2025

Includes: Supplemental data

Journal Articles

Allo-HCT in Hodgkin lymphoma after CPI

Blood (2025) 146 (8): 1030.

https://doi.org/10.1182/blood.2025030720

Published: 2025

Journal Articles

Cracking the POD24 code in follicular lymphoma

Florian Scherer

Blood (2025) 146 (8): 899–900.

https://doi.org/10.1182/blood.2025029930

Published: 2025

Journal Articles

A burden too high for CAR T cells in CLL

Arnon P. Kater, Maria Themeli

Blood (2025) 146 (8): 901–902.

https://doi.org/10.1182/blood.2025029368

Published: 2025

Journal Articles

Protecting the epithelium and taming GVHD

Yishan Ye, Mohamad Mohty

Blood (2025) 146 (8): 903–905.

https://doi.org/10.1182/blood.2025029271

Published: 2025

Journal Articles

The landscape of disease: mapping aplastic anemia

Patrick M. Brunner

Blood (2025) 146 (8): 905–906.

https://doi.org/10.1182/blood.2025029791

Published: 2025

Journal Articles

Deep dive into shallow myeloma cell pool

Mehmet K. Samur

Blood (2025) 146 (8): 906–907.

https://doi.org/10.1182/blood.2025029778

Published: 2025

Journal Articles

CALR-ifying ATF6/BCL-xL activation by type 2 CALR mutations

Fan He, Stephen T. Oh

Blood (2025) 146 (8): 907–908.

https://doi.org/10.1182/blood.2025029864

Published: 2025

Journal Articles

When TNFα is out, IFN-γ drives anemia of inflammation

Laura Silvestri

Blood (2025) 146 (8): 908–910.

https://doi.org/10.1182/blood.2025030006

Published: 2025

Journal Articles

Checkpoint-primed allo-HCT in HL: cure gains, risk remains

Paul J. Bröckelmann, Bastian von Tresckow

Blood (2025) 146 (8): 911–912.

https://doi.org/10.1182/blood.2025029908

Published: 2025

Journal Articles

ZUMA-8: a phase 1 study of brexucabtagene autoleucel in patients with relapsed/refractory chronic lymphocytic leukemia

Matthew S. Davids, Saad S. Kenderian, Ian Flinn, Brian T. Hill, Michael Maris, Paolo Ghia, Michael Byrne, Nancy L. Bartlett, John M. Pagel, Yan Zheng, Justyna Kanska, Wangshu Zhang, Enrique Granados, Javier Pinilla-Ibarz

Blood (2025) 146 (8): 938–943.

https://doi.org/10.1182/blood.2024027460

Published: 2025

Includes: Supplemental data

Journal Articles

The T follicular helper/T follicular helper regulatory pathway in FVIII immune responses in mice

Weiqing Jing, Jocelyn A. Schroeder, Saurabh Kumar, Juan Chen, Yuanhua Cai, Lynn M. Malec, Alexander L. Dent, Weiguo Cui, Qizhen Shi

Blood (2025) 146 (8): 998–1010.

https://doi.org/10.1182/blood.2025029470

Published: 2025

Includes: Supplemental data

Journal Articles

Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT

Eduard Schulz, Lauren M. Curtis, Noa G. Holtzman, Seth M. Steinberg, Kaska Wloka, Alen Ostojic, Alain Mina, Najla El Jurdi, Filip Pirsl, Ashley Carpenter, Mahshid Golagha, Arlene Sirajuddin, Theo Heller, Brian C. Shaffer, Frances T. Hakim, Jeffrey S. Rubin, Ronald E. Gress, Steven Z. Pavletic

Blood (2025) 146 (8): 944–950.

https://doi.org/10.1182/blood.2024028303

Published: 2025

Includes: Supplemental data

Journal Articles

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment

Blood (2025) 146 (8): 964–970.

https://doi.org/10.1182/blood.2025029234

Published: 2025

Includes: Supplemental data

Journal Articles

Challenges in GVHD and GVL after hematopoietic stem cell transplantation for myeloid malignancies

Gerard Socie

Blood (2025) 146 (8): 926–937.

https://doi.org/10.1182/blood.2025028617

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis

Blood (2025) 146 (8): 1011–1029.

https://doi.org/10.1182/blood.2024027197

Published: 2025

Includes: Supplemental data

Journal Articles

Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment

Blood (2025) 146 (8): 913–925.

https://doi.org/10.1182/blood.2024027727

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Remestemcel-L-rknd (Ryoncil): the first approved cellular therapy for steroid-refractory acute GVHD

Mitochondrial DNA via recipient TLR9 acts as a potent first-hit in murine transfusion-related acute lung injury (TRALI)

F8 gene variants influence the response to desmopressin in hemophilia A carriers

Artificial Intelligence in Hematology

Allo-HCT in Hodgkin lymphoma after CPI

Cracking the POD24 code in follicular lymphoma

A burden too high for CAR T cells in CLL

Protecting the epithelium and taming GVHD

The landscape of disease: mapping aplastic anemia

Deep dive into shallow myeloma cell pool

CALR-ifying ATF6/BCL-xL activation by type 2 CALR mutations

When TNFα is out, IFN-γ drives anemia of inflammation

Checkpoint-primed allo-HCT in HL: cure gains, risk remains

ZUMA-8: a phase 1 study of brexucabtagene autoleucel in patients with relapsed/refractory chronic lymphocytic leukemia

The T follicular helper/T follicular helper regulatory pathway in FVIII immune responses in mice

Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment

Challenges in GVHD and GVL after hematopoietic stem cell transplantation for myeloid malignancies

Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis

Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only